A detailed history of Atlantic Union Bankshares Corp transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Atlantic Union Bankshares Corp holds 5,297 shares of NUVB stock, worth $12,183. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,297
Holding current value
$12,183
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

BUY
$1.66 - $2.53 $8,793 - $13,401
5,297 New
5,297 $10,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $500M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Atlantic Union Bankshares Corp Portfolio

Follow Atlantic Union Bankshares Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Union Bankshares Corp, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Union Bankshares Corp with notifications on news.